Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Schumer Senate Legalization Bill set for April Vote
The Cannabis Administration & Opportunity Act (CAOA) is a bill to legalize cannabis that was developed by Majority leader Chuck Schumer in the Senate which has the best chance of becoming law. The MORE Act has passed the House 6 times only to be voted down in the Senate, and the House is voting on it again today.
Meanwhile, advocates and stakeholders are eagerly awaiting the formal introduction of a separate Senate legalization bill that’s being finalized by Majority Leader Chuck Schumer (D-NY) and colleagues. Schumer recently said the plan is to file that bill—the Cannabis Administration & Opportunity Act (CAOA)—in April.
Meanwhile, on the same day that it was announced that the MORE Act would be heading to the floor again, the Senate unanimously approved a bipartisan bill meant to promote research into marijuana, in part by streamlining the application process for researchers who want to study the plant and to encourage the Food and Drug Administration (FDA) to develop cannabis-derived medicines.
Legalization would add BILLIONS in Revenue
After House leadership confirmed the chamber would again be voting on the MORE Act, the majority and minority leaders of the Judiciary Committee released a nearly 500-page report on what the legislation would accomplish and outlining arguments for and against the reform.
Also, following the Rules Committee vote on Wednesday, the Congressional Budget Office (CBO) released a report finding that enacting the MORE Act would add billions in revenues and reduce prison costs over the next decade.
https://www.marijuanamoment.net/house-begins-debate-on-federal-marijuana-legalization-bill-with-praise-from-pelosi-ahead-of-floor-vote/
You certainly deserve it LOL
LOL, hope you sold right?
What a clown
I don't think so
They just hired the auditing firm, I don't think there is anyway they could go back 2 years and audit everything but that is just a guess.
I would think it could take 6 months and would get us off the pink and to higher level of OTC which would be nice.
The last debt was 212M shares in 8/26/21
All this debt had to be converted before the Artizen merger on 9/1/21 in my opinion.
All the debt conversions, there were 4 of them, that started 4/7/21 and the total shares issued was 412M that covered total of $412k debt.
That is why we have to be close to done, if you do the math.
Looks like 6M Conversion so far today.
They will need to cover the shorted trade near the close or just after close, it will show as a volume of 12M out of the total traded today when the Conversion shares are used to cover the trade for the MM.
Real shareholder trading is next to nothing, higher prices are coming as soon as this Debt is eliminated. IMO it is any day now we shall see.
PVSP Bid Whacks too funny, 9k for $18,LOL
Seriously such foolishness.
Multiple Cannabis Legalization Bills Coming!
Key House Committee Formally Clears Federal Marijuana Legalization Bill For Floor Vote This Week
March 30, 2022
The so called MORE act passed rules comm and is up for vote on floor Friday. Not clear if the Senate would pass it, many amendments were added and deleted in rules comm. Probably a 50/50 chance at best. This bill was rejected by Senate in 2021.
Meanwhile, advocates and stakeholders are eagerly awaiting the formal introduction of a separate Senate legalization bill that’s being finalized by Majority Leader Chuck Schumer (D-NY) and colleagues. Schumer recently said the plan is to file that bill—the Cannabis Administration & Opportunity Act (CAOA)—in April.
The CAOS is the one that has the best chance of passing as it came out of the Senate and if it passes the Senate really good chance it will get approved into law.
Also in Congress, a separate bill to tax and regulate marijuana is also in play this session. Rep. Nancy Mace (R-SC) is sponsoring that legislation, and she said in a recent interview that she’s received assurances from Democratic leaders that her States Reform Act will receive a hearing following the MORE Act floor vote.
It really is a matter of time before Cannabis will be legalized in the US, mostly politics for now in what the language should be, not that it should be legalized.
https://www.marijuanamoment.net/more-amendments-to-federal-marijuana-legalization-bill-filed-ahead-of-floor-vote/
No Conversion yesterday or Today ?
Conversion debt could be done, none yesterday and none today so far.
If it is finished, the stock price is going to RUN BiG TIME and the no more cheapies!!
Management doing great job managing Expectations!
They state that goal early on and they are doing great job in managing shareholder expectations with the release of expansion news and new deals.
By including Revenue Expectations with each new deal announcement helps shareholders get a realistic view of the revenue that is being projected from the deal.
Remember this when the company meets or exceeds these projection in the future.
CEO Shareholder Letter 3 months ago
German is doing exactly what he said he was going to do in the attached Letter to Shareholders released in January. Exciting times for PVSP in 2022 and beyond.
OTC DISCLOSURE & NEWS SERVICE
Pervasip Releases Shareholder Letter
Press Release | 01/04/2022
Seattle, Washington--(Newsfile Corp. - January 4, 2022) - Pervasip Corp. (OTC Pink: PVSP) ("Pervasip" and the "Company") today announced that its President and Chief Executive Officer, German Burtscher, issued the following letter to Pervasip's shareholders:
Dear Shareholders:
We ended 2021 with numerous accomplishments, healthy financials, an amazing lineup of new opportunities, various strategic initiatives, and a companywide restructuring that we concluded over the past 3 months, after completing our acquisitions of Artizen Corporation ("Artizen") and its subsidiary, Zen Asset Management LLC ("ZAM") in September 2021.
We have an amazing foundation to grow from in 2022, including close to $17 million in annual revenues, positive EBIDTA, one of the most established cannabis management companies in Washington state, and the intellectual property behind one of the top 10 national cannabis brands.
Our plan for 2022 is to rapidly expand ZAM's position as a platform operator in the Western United States and broaden the market reach for the Artizen brand, including by increasing yields, adding new offerings, and establishing the Artizen brand in new markets. We already have significant progress on each front that we are excited to share over the coming months.
With our investment in KRTL Biotech we are also starting to review the medicinal fungi market for unique product and other growth opportunities. In addition, with the recent approval obtained by the Ministry of Food and Drug Safety (MFDS), formerly known as the Korea Food & Drug Administration (KFDA), KRTL is commencing research that will better assist the medical and psychological community in the treatment of specific disorders, which include pain resulting from cancer treatment, autism, PTSD, ADHD, depression, addiction, improvement in concentration and other psychological illnesses.
This is an exciting time for us and I urge you to be on the lookout for a stream of announcements over the next 6 months as we race into 2022. We look forward to our next communication. Until then, thank you for your continued interest and support.
Best Regards,
German Burtscher
President and Chief Executive Officer
Pervasip Corp.
House poised to pass bill legalizing marijuana
The Hill
BY CRISTINA MARCOS - 03/28/22 06:00 AM EDT
The House is poised to pass legislation this week that would legalize marijuana, just the latest example of the swiftly changing attitudes on drug laws that marks a near reversal from the Reagan-era war on drugs that also reverberated through the 1990s.
The bill legalizing marijuana has near-uniform support among Democrats and a top ally in Senate Majority Leader Charles Schumer (N.Y.), who has been aiming to introduce a similar measure this spring.
And it’s just one of several pieces of legislation that underlines the shift in Congress’s attitude — a change that has come about in part because of the way past drug laws have disproportionately hit minority communities.
https://thehill.com/homenews/house/599820-house-poised-to-pass-bill-legalizing-marijuana
NEWS: PVSP and FSA Agreement
Seattle, WA, March 29, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, and Zen Asset Management (“ZAM”), its wholly owned subsidiary, today announced that it entered into a strategic partnership with Full Spectrum Advisors (“FSA”), a cannabis cultivation group that has designed and operated over 7 million square feet of indoor canopy along with pioneering cutting edge crop steering techniques.
Following prior annoucened efforts to upgrade all facilities and materially improve on harvest yields, Pervasip and FSA have agreed to partner to substantially improve the overall growth of the company and broaden its revenue base. FSA has sucecsfully rolled out topshelf multi-state brands over the past years and brings years of development and garden management expertise focused on high quality flower and unique genetics.
“Our independent cultivators, utilizing our facilities, combined with the overall potential in Washington State have barely begun to take advantage of all the pportunities for revenue locked up in this network” said German Burtscher, the company’s President & CEO. “We will see substantioal increases not only in harvest yields but also genetic diversity, and improved product quality which will lead to substiantial growth over the next two to three years, not only in Washington, but as the Artizen brand expands into other recreational cannabis markets”.
The FSA team brings years of experience in some of the most recognized cultivation environments and with some of the most well known cannabis brands. “We are very excited to partner with Pervasip and ZAM to assist in the upgrades of all indoor facilities, grow SOPs and a genetic refresh which will allow ZAM’s independent cultivators to strategically grow exceptional flower for the Artizen brand. This is a multi-year effort that we are committing to and we look forward to working with the ZAM staff to implement our plan”, said Isaiah Dawid, FSA’s CEO.
2022 Is Not the Time to Give Up on Marijuana Stocks
Motley fool
By Sushree Mohanty - Feb 4, 2022 at 6:33AM
KEY POINTS
Domestic pot growers are already in good shape.
More state legalization this year will boost the stock price.
Don't lose hope -- the cannabis industry is expected to double by 2026.
The sun will shine again on the cannabis sector.
2021 was a dreadful year for marijuana stocks. The industry benchmark, the Horizons Marijuana Life Sciences ETF, dipped 54% compared to the S&P 500's gain of 20%.
However, that doesn't mean the sector is doomed and all hope is lost. Smart investors are aware that highs and lows are common in an evolving industry. The sector took a hit last year because of the lack of positive movement toward the federal legalization of marijuana. But there is no stopping this industry's growth, which is expected to double by 2025.
Though I am not in favor of the Canadian pot stocks (except Tilray), which might take a few years to rebound, U.S. cannabis companies continue to impress with their outstanding financials and expansion strategies. These growth stocks are an excellent addition to one's portfolio to earn long-term returns.
Let's take a look at why 2022 is not the time to give up on marijuana stocks.
https://www.fool.com/investing/2022/02/04/2022-is-not-the-time-to-give-up-on-marijuana-stock/
House Rules Committee meeting vote now Wednesday
POLITICS
Bipartisan Lawmakers File Amendments To Federal Marijuana Legalization Bill Up For House Vote This Week.
The House Rules Committee meeting where the amendments will be either blocked from further consideration or advanced toward votes by the full body was originally scheduled for Monday, but that’s now been pushed back to Wednesday. So far, five amendments have been introduced—but it’s possible that more will be filed in the days to come.
Looks like a lot of amendments are getting added, as usual.
PVSP #3 on Breakout Boards
Go figure, but always nice to get some more eyeballs on our company.
Investorshub.advfn.com/boards/breakoutboards.aspx
Schumer's Legalization Bill coming in a few months
We will get one through the Senate eventually this year is my hope. We could get a surprise and this one passes the senate, but IMO it is going to take a few more tries and some outrage from the public that are growing tired of the Senates BS and not doing the will of the people.
Our outdated marijuana laws put Americans in danger.
USA Today, Feb22, 2022
It's past time for federal cannabis reforms.
The simple truth is that continued federal cannabis prohibition is neither tenable nor the will of the American electorate.
Travis Mason, a former Marine working as a cannabis dispensary security guard, dreamed about becoming a police officer. That dream never came true. In 2016, Travis was shot and killed during a robbery at work.
Tragically, crimes like the one that took Travis' life aren't uncommon. Why? Because the federal government can't get out of its own way.
Under federal law, institutions providing financial services to legitimate, state-legal cannabis businesses are subject to criminal prosecution. Credit card companies won’t process transactions from dispensaries, and most banks won’t give loans or allow state-legal cannabis businesses to open accounts. This forces small businesses to operate in all cash, making them and their employees sitting ducks for violent robberies.
That’s why Rep. Ed Perlmutter, a Democrat from Colorado, introduced the SAFE Banking Act. This bipartisan bill would eliminate public safety hazards, grant state-legal businesses access to the banking system, and allow the IRS to more effectively collect its fair and substantial share of taxes.
https://www.usatoday.com/story/opinion/2022/02/21/federal-marijuana-laws-cannabis-reform/6801358001/
PVSP Tweeter: Cannabis Legalization
Hello $PVSP shareholders:
Cross your fingers! Big week for cannabis legalization. Rules will pass and then on to floor votes and Senate!
12:39 PM · Mar 28, 2022·Twitter for Android
Hello $PVSP shareholders:
— Pervasip Corp (@PervasipC) March 28, 2022
Cross your fingers! Big week for cannabis legalization. Rules will pass and then on to floor votes and Senate!
Just converted $1.5M at .01 per share
Cannabis companies have been valued as high as 10 times trailing revenue, as most are growing at high rates from 50 to 100%.
Even now when most are down 80% from recent highs last year, the typical valuation has dropped as low as 2.5 trailing revenue.
PVSP has trailing revenue of $17M with forward revenue projection of nearly $40M for 2022 with new expansion of growing facilities and multi state expansion.
Valuations are forward looking, and PVSP is looking at $50M valuation with price of .01, recently it's market value was $8M, less than physical assets, and less than 50% of trailing revenue.
Debt conversion was part of the reason but that debt was being converted to clean up the new company balance sheet.
We are an early stage start up, 5 years old. Profitability is NOT a the goal right now, GROWTH is the goal. Do you think Tesla, or Amazon was worried about Profitability for the first 10 years?
Of course not, profitability comes from SCALE.
You should be looking at GROWTH, 100% a year is fantastic!
All Mammoth Debt Converted prior to Artizen Deal 9/1/21
4-7-21 157M at.001 for $157k Debt Conversion
7-20-21 50M at .001 for $50k Debt Conversion
8-26-21 212M at .001 for $212k Debt Conversion
Total of 419M shares to Convert $419k Debt
This was all done prior to Artizen acquisition as most here discussed back then.
Non issue get ready to rock!!
POLITICS Bipartisan Congressional Lawmakers Demand Marijuana Legalization Bill ‘Expeditiously’ Get House Vote
February 2, 2022
Kyle Jaeger
A bipartisan coalition of House lawmakers on Wednesday sent a letter to congressional leadership, demanding that a bill to federally legalize marijuana be “expeditiously” taken up by Congress.
The letter, led by Rep. Marilyn Strickland (D-WA), urges action on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act—a bill sponsored by House Judiciary Committee Chairman Jerrold Nadler (D-NY) that cleared the House in a historic first in 2020 and has since passed the sponsor’s panel again this session but has not yet been scheduled for floor consideration.
The legislators are also making the request on broad marijuana reform as the House is set this week to take up a more incremental proposal again to protect banks that work with state-legal cannabis businesses after it’s already cleared the chamber five times in some form.
Advocates have been eager to see the comprehensive MORE Act reconsidered on the floor in the new session, especially with Democrats now in control of both chambers as well as the White House.
https://www.marijuanamoment.net/bipartisan-congressional-lawmakers-demand-marijuana-legalization-bill-expeditiously-get-house-vote/
Cannabis stocks rally on flurry of federal moves toward legalization
Published: March 25, 2022 at 8:11 a.m. ET
By Steve Gelsi
While federal legalization remains elusive, lawmaker actions have boosted moribund cannabis stocks
Lawmakers taking fresh steps toward federal legalization of cannabis sparked a rally in cannabis stocks on Friday.
Following through on big moves higher in the previous session, beaten-up shares of cannabis stocks started getting off the mat.
The U.S. House of Representatives is expected to vote for the second time on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act that would legalize cannabis. The news was reported in a Thursday article in Marijuana Moment.
The bill is on a list of other measures that House leaders plan to take up on the House floor next week.
An earlier version cleared the House in 2020 but later stalled in what was a Republican-majority Senate.
Separately, the Senate on Thursday passed legislation sponsored by Sens. Dianne Feinstein (D, Calif.), Chuck Grassley (R, Iowa) and Brian Schatz (D, Hawaii) to expand scientific and medical research on cannabis and its compounds.
“Current rules and regulations make it hard for researchers to study how marijuana and marijuana-derived medications can best be used to treat various conditions,” Feinstein said in a statement. “This important legislation will cut the red tape around the research process, helping get FDA-approved, marijuana-derived medications safely to patients.”
Shares of both Canadian and American-based cannabis companies rose Friday after moving higher in the previous session. Companies from both sides of the border have been working to tap into the U.S. market.
Grow Solutions up 100% , PVSP soon!!
How about those Shorts feeling a little heat.
Check out the BID whacks, LOL
1,000 shares for $1.90
70 shares for .13 cents
Trolls are desperate, stock price is going to run and they don/t know what to do but Whack the BID for a few pennies, LOL
PVSP up 11%
Grow Solutions up 50%
Marijuana co America up 40%
Sundial up 12%
Sector heating up big time!!
Cannabis Stocks ON FIRE pre market again
Sundial already up another 20% on over 31M shares traded premarket.
PVSP is even more undervalue and breakout is coming today or next week.
Aurora up 15%
Canopy Growth up 13%
Tilray up 18%
Huge Day for Cannabis as we may have seen the low for the year!
Federal MJ Legalization Bill Vote Next Week
The U.S. House of Representatives plans to vote on a bill to federally legalize marijuana for the second time in history next week, congressional leadership confirmed on Thursday.
The body will take up the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, a bill sponsored by House Judiciary Committee Chairman Jerrold Nadler (D-NY). An earlier version of the measure cleared the chamber last session but later stalled in what was then the Republican-controlled Senate.
The legislation, which would remove cannabis from the list of federally controlled substances and promote social equity in the industry, cleared the Judiciary Committee again this session, and activists have been pushing for a floor vote this month.
Rumors of potential floor action next week began circulating on Wednesday, with sources telling Marijuana Moment that while nothing had been confirmed yet, the official vote scheduling appeared imminent based on high-level discussions they were familiar with.
Now, House leaders have officially placed the cannabis legislation on a list of bills they plan to take up on the House floor next week. The Rules Committee will officially take up the measure in a meeting on Monday afternoon to prepare it for floor action, including by determining which amendments will be allowed to advance for consideration.
The last time the MORE Act went to the floor in December 2020, it passed in a 228-164 vote, with just five Republicans joining their Democratic colleagues in advancing the reform. One of those five GOP members, Rep. Don Young (R-AK), died last week. He was one of bipartisan co-chairs of the Congressional Cannabis Caucus.
https://www.marijuanamoment.net/federal-marijuana-legalization-bill-officially-scheduled-for-house-floor-vote-next-week/
Federal Official revealing MJ Legalization
POLITICS
Top Federal Drug Official Blows Senator’s Mind By Revealing Marijuana Legalization Doesn’t Increase Teen UsePublished 2 days ago on March 23, 2022By Kyle Jaeger
A top federal drug official reiterated on Wednesday that adolescent marijuana use has not increased in states that have moved to legalize cannabis, much to the surprise of a GOP senator who said he expected otherwise based on alcohol-related trends.
National Institute on Drug Abuse (NIDA) Director Nora Volkow addressed the issue at a hearing before the Senate Health, Education Labor & Pensions (HELP) Committee. She did raise some concerns about potential health risks of marijuana use overall, but made clear that the evidence does not support a common prohibitionist argument that reforming cannabis laws leads to increased underage consumption.
“Specifically in the United States, legalization by some states of marijuana has not been associated with an increase in adolescents’ marijuana use,” Volkow said in response to a question from Sen. Bill Cassidy (R-LA).
The senator, whose home state of Louisiana last year decriminalized cannabis possession but has not legalized commercial sales of non-medical marijuana, was taken aback.
“That surprises me, because if you relax blue laws for alcohol, there ends up being more alcohol used by adolescents in that given county or parish,” Cassidy replied, referring to policies in place in several states where alcohol purchases are restricted or prohibited on certain days, typically Sundays.
https://www.marijuanamoment.net/top-federal-drug-official-blows-senators-mind-by-revealing-marijuana-legalization-doesnt-increase-teen-use/
HUGE NEWS: Congress to vote on Legalization
Congress plans to vote on federal legalization of the drug next week
Cannabis stocks soared on Thursday after a report said Congress has scheduled a vote to legalize the drug.
The U.S. House of Representatives will reportedly vote next week on the Marijuana Opportunity, Reinvestment and Expungement Act.
If enacted, the bill would remove cannabis from the list of federally controlled substances.
https://markets.businessinsider.com/news/stocks/congress-vote-federal-legalization-marijuana-cannabis-stock-prices-senate-2022-3
Cannabis Stocks ON FIRE!!!
That merger recently has set the sector on FIRE today!
USMJ up 20%
MCOA up 71%
SNDL up 23%
GGKK up 9%
ACB up 11%
CGC up 12%
PHOT up 34%
MJNA up 38%
GRNH up 44%
and many more!!
Smart money stealing shares LOL
Not many sellers left at these levels. 2/3 of daily trades are just part of the conversion of debt that is underway.
As BID builds, MM will short 2 to 4M shares to the BID, and then at end of day or after hours they will cover those trades with the converted shares, usually a TIC below the BID so they make a buck for their trouble.
The 4M shorted get recorded as 4M and the 4M conversion covered shows 4M and you get 8M shares traded which inflates the daily volume significantly.
Shareholders are NOT SELLING, most are accumulating and the debt conversion is presenting the opportunity to buy these cheapies!!
LOL, sorry, LOL
LOL, LOL, LOL! Too funny seriously.
No buyers? We buy EVERYDAY, LOL, LOL
Every single share sold has been Bought!! LOL, LOL
Smart Money Accumulating Shares
Some complain about share price being down.
Smart Money says it is what it is, I think I will take advantage of the opportunity.
If you LIKED it at .003, you should LOVE it at .0018! LOL
Sure looks like the Conversions are DONE!
We will see, but the volume says they could be over, but we need to see the close.
If we are done, that will be the end of the CHEAP shares and UP we will go!
2.8M traded all day, LOL!!
Yea right big sell over, $6k all day. LOL
Could the Conversions be DONE?
It sure looks like it, only 1.7M shares traded as of 1PM is looking like we may finally be done and the Debt is cleaned up.
If the conversions are done, the stock price is going to explode to the upside.
Yesterday conversion was 5.6M shares and a Form T trade after hours, to cover the MM shorted shares from normal hours.
Cresco will get access to 17 States, PVSP soon
Cresco Labs to Buy Columbia Care in $2 Billion Cannabis Deal
Deal will expand Cresco reach to 17 states, up from 10
Marijuana industry is consolidating amid U.S. legal hurdles
ByTiffany Kary
March 23, 2022, 6:2 Follow 2 AM EDTUpdated onMarch 23, 2022, 10:14
Cresco Labs Inc. plans to buy Columbia Care Inc. for about $2 billion in one of the largest cannabis industry mergers yet.
The deal will combine Cresco’s well-recognized marijuana brands with New York-based Columbia Care’s retail footprint to create the largest U.S. multistate operator by revenue, Cresco Chief Executive Officer Charles Bachtell said in an interview.
Bachtell, who will lead the combined company, said the transaction will expand Cresco’s presence to 17 states, plus the District of Columbia, up from 10 states. It will also give Chicago-based Cresco the top market share in Illinois, Pennsylvania, Colorado and Virginia.
Cresco now Largest US Cannabis Co.
Chicago now center of the US cannabis market in $2 BILLION Deal
March 23, 2022 06:34 AM UPDATED AN HOUR AGO
Cresco buying rival to become largest U.S. cannabis company
The $2 billion purchase of Columbia Care gives Cresco access to new markets and cements Chicago’s place at the center of the legal-marijuana industry.
Columbia Care acquired by Cresco in $2B deal. The purchase makes the Chicago-based firm the largest marijuana company in the U.S. and gives it access to new markets like New Jersey http://ow.ly/hmCv103v2C5
In this article:
CRLBF
-6.28%
CL
-0.95%
Company reports 73% year-over-year revenue growth and 219% adjusted EBITDA growth in 2021
CHICAGO, March 23, 2022--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), a vertically integrated, multi-state operator and the number one U.S. wholesaler of branded cannabis products, today released its financial results for the three months and year ended December 31, 2021. All financial information presented in this release is reported in accordance with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and in U.S. dollars, unless otherwise noted, and all comparisons to prior quarters and the prior year are made on an as-converted basis under U.S. GAAP.
The Company announced today it has entered into a definitive arrangement agreement pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Columbia Care (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF). A separate press release with details of the proposed transaction was issued this morning.